Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K AMENDMENT - Vaxart, Inc. | d465328d8ka.htm |
| EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF NABI AND BIOTA - Vaxart, Inc. | d465328dex993.htm |
| EX-99.1 - AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF BIOTA - Vaxart, Inc. | d465328dex991.htm |
| EX-99.2 - UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF BIOTA - Vaxart, Inc. | d465328dex992.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-115691, No. 333-115688, No. 333-109017, No. 333-38864, No. 333-38868, No. 333-95269, No. 333-56037, No. 333-56071, No. 033-65069, No. 033-60795, No. 333-134954, No. 333-143238 and No. 333-143239) of Biota Pharmaceuticals, Inc. of our report dated January 22, 2013 relating to the financial statements of Biota Holdings Limited, which appears in this Current Report on Form 8-K/A filed on January 23, 2013.
/s/ PricewaterhouseCoopers
Melbourne, Australia
January 22, 2013